RMD NYSE
ResMed Inc.
1W: +3.2%
1M: -5.9%
3M: -19.3%
YTD: -14.4%
1Y: -15.4%
3Y: -6.4%
5Y: +11.2%
$208.05
-0.93 (-0.45%)
After Hours: $210.83 (+2.78, +1.34%)
Weekly Expected Move ±3.9%
$186
$194
$202
$210
$218
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.60
Bullish
2 bullish
1 neutral
0 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (100)
Is the Options Market Predicting a Spike in ResMed Stock?
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Silver Economy Investing: Why the Healthcare Giants Are in Focus
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
Here's Why ResMed (RMD) is a Strong Growth Stock
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
ResMed declares $0.60 dividend
RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise
ResMed expects FY 2026 gross margin of 62%-63% as it plans $175M+ Q4 buybacks and targets June 1 close for $340M Noctrix deal
ResMed (RMD) Q3 2026 Earnings Transcript
Transcript: ResMed Q3 2026 Earnings Conference Call
ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates
ResMed (RMD) Reports Q3 Earnings: What Key Metrics Have to Say
ResMed announces CFO succession
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
Here are the major earnings after the close Thursday
Earnings Scheduled For April 30, 2026
Wall Street's Insights Into Key Metrics Ahead of ResMed (RMD) Q3 Earnings
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Arizona State Retirement System Trims Stock Position in ResMed Inc. $RMD
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
Resmed's Q3 Earnings on Deck: What's in Store for the Stock?
Why ResMed (RMD) is Poised to Beat Earnings Estimates Again
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD
Should You Continue to Hold Resmed Stock in Your Portfolio?
Abbott stock slips on guidance cut, ranks 10th in healthcare equipment Quant ratings
Aaron Wealth Advisors LLC Sells 2,210 Shares of ResMed Inc. $RMD
Azzad Asset Management Inc. ADV Has $1.08 Million Stock Position in ResMed Inc. $RMD
4,837 Shares in ResMed Inc. $RMD Acquired by Runnymede Capital Advisors Inc.
4,837 Shares in ResMed Inc. $RMD Acquired by Runnymede Capital Advisors Inc.
GraniteShares Advisors LLC Has $58,000 Stock Holdings in ResMed Inc. $RMD
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Sells 2,674 Shares of ResMed Inc. $RMD
Element Squared LLC Buys Shares of 6,067 ResMed Inc. $RMD
Aberdeen Group plc Sells 37,737 Shares of ResMed Inc. $RMD
Banque Pictet & Cie SA Sells 4,207 Shares of ResMed Inc. $RMD
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
SG Americas Securities LLC Cuts Stock Position in ResMed Inc. $RMD
Assenagon Asset Management S.A. Has $19.43 Million Stock Holdings in ResMed Inc. $RMD
Congress Asset Management Co. Has $900,000 Stock Position in ResMed Inc. $RMD
Citi's large-cap stocks with negative ROE trends
After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)
Danske Bank A S Buys New Stake in ResMed Inc. $RMD
Achmea Investment Management B.V. Decreases Stake in ResMed Inc. $RMD
ResMed (RMD) Upgraded to Buy: Here's What You Should Know
Is Resmed Stock the Right Pick for Your Portfolio Now?
After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)
Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions
Aquatic Capital Management LLC Buys 12,642 Shares of ResMed Inc. $RMD
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus
2Xideas AG Acquires 8,397 Shares of ResMed Inc. $RMD
Here's How Much You Would Have Made Owning ResMed Stock In The Last 10 Years
Bank of Montreal Can Sells 128,166 Shares of ResMed Inc. $RMD
3 Reasons Not to Sleep on ResMed Stock
American Century Companies Inc. Sells 94,015 Shares of ResMed Inc. $RMD
Dundas Partners LLP Acquires 22,933 Shares of ResMed Inc. $RMD
First Trust Advisors LP Buys 329,588 Shares of ResMed Inc. $RMD
ResMed Inc. $RMD Shares Sold by Blair William & Co. IL
Crossmark Global Holdings Inc. Purchases 17,487 Shares of ResMed Inc. $RMD
ResMed Inc. $RMD Shares Purchased by Fisher Asset Management LLC
Here's How Much You Would Have Made Owning ResMed Stock In The Last 10 Years
Disney, Toast, ServiceNow And A Health Care Stock On CNBC's 'Final Trades'
Elo Mutual Pension Insurance Co Raises Stock Position in ResMed Inc. $RMD
APG Asset Management N.V. Sells 2,024 Shares of ResMed Inc. $RMD
Andra AP fonden Cuts Stock Holdings in ResMed Inc. $RMD
Aster Capital Management DIFC Ltd Acquires New Shares in ResMed Inc. $RMD
ResMed At $250: Missed Opportunity Or A Trap In The Making?
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
Apriem Advisors Lowers Holdings in ResMed Inc. $RMD
Aberdeen Group plc Has $75.94 Million Stake in ResMed Inc. $RMD
ResMed Inc. (NYSE:RMD) Receives Average Recommendation of “Moderate Buy” from Brokerages
RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand
ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell
Analysts Maintain Bull Case On ResMed Despite Competition Concerns
AlphaQuest LLC Grows Stock Position in ResMed Inc. $RMD
ResMed Q2 Earnings Call Highlights
ResMed Inc (RMD) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations
ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript
ResMed (RMD) Reports Q2 Earnings: What Key Metrics Have to Say
ResMed (RMD) Q2 Earnings and Revenues Beat Estimates
ResMed beats quarterly profit estimates on strong demand for its sleep devices
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
Here's Why ResMed (RMD) is a Strong Momentum Stock
Are Medical Stocks Lagging ResMed (RMD) This Year?
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics
Resmed's Q2 Earnings on Deck: What's in Store for the Stock?
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
Wealth Enhancement Advisory Services LLC Raises Stake in ResMed Inc. $RMD
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ResMed Inc. (NYSE:RMD) Receives Average Rating of “Moderate Buy” from Brokerages
Bet on These 5 Low-Leverage Stocks to Avoid Industrial Volatilities
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Peter Farrell Sells 2,000 Shares of ResMed (NYSE:RMD) Stock
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Here's Why ResMed (RMD) is a Strong Growth Stock